Diagnosed days before hosting 100K country music fans
Sarah Trahern is CEO of the Country Music Association (CMA). Read her T1D story.
We are Breakthrough T1D
As the leading global type 1 diabetes (T1D) research and advocacy organization, we’re here to make every day life with T1D better.
Never Let T1D Dim Your Light
Princess Padmaja Kumari Parmar combats the stigma of T1D as a Global Ambassador for our organization.
C-Peptide as an Endpoint in Clinical Trials: Its Time Has Come
A new publication provides more evidence for C-peptide as a validated surrogate to predict clinical benefits of disease-modifying therapies in T1D.
A New Shot on Goal for Cell Therapies In T1D
Eledon Pharmaceuticals announces new funding from the T1D Fund and the launch of their clinical trial for tegoprubart in T1D.
The Kelley Family: Enduring to Cure T1D
The Kelley family is involved with our organization in every way possible. But for Margaret Kelley, our endurance event is magical, and she can't imagine running any other way.
The Merwin Family: Aiming for the Ultimate Finish Line
The Merwin Family found their purpose with our organization after their child was diagnosed with T1D.
Meet Our New International Board of Directors Vice Chair, Matt Varey
Matt Varey, the newly elected Vice Chair of the Breakthrough T1D International Board of Directors (IBOD), brings a truly global voice as the first Canadian and the first person outside of the U.S. to serve in the role.
Beating the Odds: The Improbable Story of How Perseverance, Belief, and Luck Led to the Approval of the First Life-Changing Immune Therapy for Type 1 Diabetes
The true story of how Tzield (teplizumab), the first disease-modifying therapy approved for use in delaying type 1 diabetes (T1D) onset, made it to market.
Breakthrough T1D One Walk Goes Virtual in Roblox
The new Charity Walk Simulator in Breakthrough T1D One World on Roblox puts players in charge of their very own virtual Breakthrough T1D One Walk!
